Basic information Safety Supplier Related

LEE011 (succinate)

Basic information Safety Supplier Related

LEE011 (succinate) Basic information

Product Name:
LEE011 (succinate)
Synonyms:
  • LEE011 (succinate)
  • 7-cyclopentyl-N,N-dimethyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)-7H-pyrrolo[2,3-d]pyrimidine-6-carboxamide succinate
  • LEE-011 succinate salt, Ribociclib succinate salt
  • Ribociclib succinate
  • Ribociclib Succinate (Kisqali)
  • RIBOCICLIB SUCCINATE (LEE011 SUCCINATE)
  • Ribociclib succite
  • RIBOCICLIB SUCCINATE (LEE011)
CAS:
1374639-75-4
MF:
C27H36N8O5
MW:
552.64
Product Categories:
  • API
Mol File:
1374639-75-4.mol
More
Less

LEE011 (succinate) Chemical Properties

Melting point:
>160oC (dec.)
storage temp. 
Refrigerator
solubility 
DMSO (Slightly), Methanol (Slightly)
form 
Solid
color 
Pale Beige
InChIKey
NHANOMFABJQAAH-UHFFFAOYSA-N
SMILES
C(C(=O)O)CC(=O)O.C(C1=CC2=CN=C(NC3N=CC(N4CCNCC4)=CC=3)N=C2N1C1CCCC1)(=O)N(C)C
More
Less

LEE011 (succinate) Usage And Synthesis

Uses

LEE011 is an orally bioavailable and highly specific CDK4/6 (cyclin-dependent kinase 4/6) inhibitor. LEE011 in combination with LGX818 (a V600E BRAF specific inhibitor) or BYL719 (a PIK3CA specific inhibitor) leads to robust anti-tumor activity in melanoma and breast cancer tumor models.

in vivo

CB17 immunodeficient mice bearing BE2C, NB-1643 (MYCN amplified, sensitive in vitro), or EBC1 (non-amplified, resistant in vitro) xenografts are treated once daily for 21 days with Ribociclib (LEE011; 200 mg/kg) or with a vehicle control. This dosing strategy is well tolerated, as no weight loss or other signs of toxicity are observed in any of the xenograft models. Tumor growth is significantly delayed throughout the 21 days of treatment in mice harboring the BE2C or 1643 xenografts (both, p<0.0001), although growth resumed post-treatment[2].

IC 50

CDK4: 10 nM (IC50); CDK6: 39 nM (IC50)

LEE011 (succinate)Supplier

Shanghai Yu Ben Biotechnology Co., Ltd. Gold
Tel
021-61350663 15502154572
Email
1639466865@qq.com
Shanghai YiWen Pharmaceutical Co., Ltd. Gold
Tel
13621628489
Email
1322392736@qq.com
Jiangxi Zhiyan Biopharmaceutical Technology Co., Ltd Gold
Tel
13970866816
Email
info@rochipharma.com
Shenzhen Yaoyuan R&D Center Co., Ltd Gold
Tel
0755-23284190 13421666688
Email
664261110@qq.com
Porton Pharma Solutions Ltd. Gold
Tel
15169181595
Email
ming.zhang3@portonpharma.com